These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8118615)

  • 1. Lysozyme as a regulator of interleukin-2-activated lymphocyte proliferation.
    Yabe N; Komiya K; Takezono T; Matsui H
    In Vitro Cell Dev Biol Anim; 1993 Oct; 29A(10):795-806. PubMed ID: 8118615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15-Deoxyspergualin inhibits interleukin 6 production in in vitro stimulated human lymphocytes.
    Borg AJ; Kumagai-Braesch M; Möller E
    Transpl Immunol; 1996 Jun; 4(2):133-43. PubMed ID: 8843590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysozyme-induced inhibition of the lymphocyte response to mitogenic lectins.
    Varaldo PE; Valisena S; Mingari MC; Satta G
    Proc Soc Exp Biol Med; 1989 Jan; 190(1):54-62. PubMed ID: 2911608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of interleukin 2 activity by delta 9-tetrahydrocannabinol after stimulation with concanavalin A, phytohemagglutinin, or anti-CD3 antibody.
    Nakano Y; Pross SH; Friedman H
    Proc Soc Exp Biol Med; 1992 Nov; 201(2):165-8. PubMed ID: 1329110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of the immunocompetence by IL-2 activation and TCR-CD3 engagement of the in vivo anergized tumor-specific CTL from lung cancer patients.
    Chen YM; Yang WK; Whang-Peng J; Tsai WY; Hung YM; Yang DM; Lin WC; Perng RP; Ting CC
    J Immunother; 1997 Sep; 20(5):354-64. PubMed ID: 9336742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and molecular aspects of transient T cell unresponsiveness: role of selective interleukin-2 deficiency.
    Köller MD; Kiener HP; Aringer M; Graninger WB; Meuer S; Samstag Y; Smolen JS
    Clin Exp Immunol; 2003 May; 132(2):225-31. PubMed ID: 12699409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
    Hess AD; Bright EC
    Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-color flow cytometric analysis of phenotype, activation marker expression, and proliferation of mitogen-stimulated bovine lymphocyte subsets.
    Quade MJ; Roth JA
    Vet Immunol Immunopathol; 1999 Jan; 67(1):33-45. PubMed ID: 9950352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
    Goodier MR; Londei M
    J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of prostaglandins on the proliferation of cultured human T lymphocytes.
    Maca RD
    Immunopharmacology; 1983 Dec; 6(4):267-77. PubMed ID: 6317610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative responses of human intraepithelial lymphocytes to various T-cell stimuli.
    Ebert EC
    Gastroenterology; 1989 Dec; 97(6):1372-81. PubMed ID: 2684720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 synergizes with IL-10 and anti-CD40 MoAbs to induce B-cell differentiation in patients with common variable immunodeficiency.
    Punnonen J; Kainulainen L; Ruuskanen O; Nikoskelainen J; Arvilommi H
    Scand J Immunol; 1997 Feb; 45(2):203-12. PubMed ID: 9042433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for an ongoing role of class I histocompatibility molecules for the production of interleukin-2 in response to suboptimal concentrations of phytohaemagglutinin.
    Hashimoto S; McCombs CC; Michalski JP
    Scand J Immunol; 1993 May; 37(5):541-9. PubMed ID: 8484101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients.
    Treisman J; Higuchi CM; Thompson JA; Gillis S; Lindgren CG; Kern DE; Ridell SR; Greenberg PD; Fefer A
    Cancer Res; 1990 Feb; 50(4):1160-4. PubMed ID: 2153452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High and low density PHA- (but not ConA-) activated T cells stimulate the autologous mixed lymphocyte reaction.
    Brahmi Z; Thomas JE
    Ann Inst Pasteur Immunol (1985); 1985; 136D(3):245-58. PubMed ID: 3006583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycine inhibits growth of T lymphocytes by an IL-2-independent mechanism.
    Stachlewitz RF; Li X; Smith S; Bunzendahl H; Graves LM; Thurman RG
    J Immunol; 2000 Jan; 164(1):176-82. PubMed ID: 10605009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1-independent activation of human T lymphocytes stimulated by anti-CD3 and a Hodgkin's disease cell line with accessory cell activity.
    Ellis TM; McMannis JD; Chua AO; Gubler U; Fisher RI
    Cell Immunol; 1988 Oct; 116(2):352-66. PubMed ID: 2972387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of human T lymphocyte proliferation by IL-4.
    Mitchell LC; Davis LS; Lipsky PE
    J Immunol; 1989 Mar; 142(5):1548-57. PubMed ID: 2783946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of noninvolvement of swine MHC class II in the in vitro proliferative response of human lymphocytes to porcine endothelial cells.
    Vallée I; Watier H; Thibault G; Salmon H; Gruel Y; Lebranchu Y; Bardos P
    Transplantation; 1995 Mar; 59(6):897-901. PubMed ID: 7701587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
    Tadmori W; Reed JC; Nowell PC; Kamoun M
    J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.